Company Profile for Kubota Vision Inc. (dba of Acucela Inc.)

Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide.

Logo
April 1, 2020 19:56 UTC

--(BUSINESS WIRE)-- Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. Kubota Vision’s development pipeline include drug candidates for the treatment of diabetic retinopathy, Stargardt disease, and optogenetics-based gene therapy for the treatment of retinitis pigmentosa. The company is also developing a handheld OCT device for the monitoring of neovascular retinal diseases, to be used directly by patients.

Company:

Kubota Vision Inc. (dba of Acucela Inc.)

Headquarters Address:

818 Stewart Street, Suite 1110

Seattle, WA 98101

Main Telephone:

+1.206.805.8300

Website:

https://www.kubotavision.com/

Type of Organization:

Private

Industry:

Biotechnology, Medical Devices, Pharmaceutical

Key Executives:

CEO: Ryo Kubota

Investor Relations

Contact:

Hiroki Maekawa

Phone:

+81.3.6550.8928

Email:

investor@kubotaholdings.co.jp

Public Relations

Contact:

Yumiko Hamanaka

Phone:

+1.206.805.8300

Email:

pr@kubotavision.com

Business Development

Contact:

- -

Email:

bd@kubotavision.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20200401005734/en/

Source: Kubota Vision Inc.

MORE ON THIS TOPIC